
The Metabolic Protocol
A targeted approach to the growth-hormone pathway and the biology of visceral fat.
Assessment required before purchase.
Check Eligibility →Free to start. Your pathway and pricing are confirmed after a short wellness assessment.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been studied for its effects on the body's natural growth hormone pathway. Research has focused particularly on visceral adipose tissue, body composition, and metabolic health.
Unlike peptides that directly provide growth hormone, tesamorelin works upstream by stimulating the body's own release of growth hormone. This makes the growth-hormone pathway central to understanding how tesamorelin is being studied.
One of the main areas of interest is visceral fat — the deeper abdominal fat stored around internal organs. Research into tesamorelin has examined changes in visceral adipose tissue and related measures of body composition, making it distinct from general weight-loss approaches.
Interest in Tesamorelin in the Philippines has grown alongside broader interest in body composition, metabolic health, and growth-hormone pathway research.
Tesamorelin is not simply another general weight-loss compound. Its research profile is more specifically connected to the growth-hormone axis and visceral adipose tissue.
For a deeper look at tesamorelin research, mechanisms, clinical evidence, and the questions surrounding its use, explore the YRT Knowledge Library.
This protocol belongs to the Metabolic pathway. Your consultation identifies whether it's the right step for your journey.

We use strictly-necessary cookies to keep you signed in and remember your cart. With your permission, we'd also like to use analytics/ad cookies (Google Analytics, Meta, TikTok) to understand traffic and measure ad performance — see our Privacy Policy for details.